Evidence map›Paper›PMID 36355864›Full record

ArticlePloS one2022

Colorectal cancer trends in Chile: A Latin-American country with marked socioeconomic inequities.

Susana Mondschein, Felipe Subiabre, Natalia Yankovic, Camila Estay, Christian Von Mühlenbrock, Zoltan Berger

Open access · goldAbstract read
In one paragraph

Article in PloS one, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 7 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
7citing papers in PubMed, 1 pooled it
0.7field-weighted citation impact, top 27% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

7 citing papers in PubMed, 1 synthesis or guideline pooled it, 9 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 5 institutions in 1 country.

Susana MondscheinIndustrial Engineering Department, Universidad de Chile, Santiago, Chile.ORCID 0000-0002-8476-0204
Felipe SubiabreIndustrial Engineering Department, Universidad de Chile, Santiago, Chile.
Natalia YankovicESE Business School, Universidad de los Andes, Las Condes, Chile.
Camila EstayDepartment of Medicine, Gastroenterology Section, Hospital Clínico de la Universidad de Chile, Santiago, Chile.
Christian Von MühlenbrockDepartment of Medicine, Gastroenterology Section, Hospital Clínico de la Universidad de Chile, Santiago, Chile.ORCID 0000-0001-5285-1147
Zoltan BergerDepartment of Medicine, Gastroenterology Section, Hospital Clínico de la Universidad de Chile, Santiago, Chile.ORCID 0000-0001-9449-933X
Hospital Clínico de la Universidad de Chile · CLClínica Las Condes · CLComplex Engineering System Institute · CLUniversidad de Los Andes, Chile · CLUniversity of Chile · CL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

introductionColorectal cancer (CRC) is the third most frequent malignant disease in the world. In some countries with established screening programs, its incidence and mortality have decreased, and survival has improved.

aimsTo obtain reliable data about the epidemiology of CRC in Chile, we analyzed the trends in the last ten years and the influence of observable factors on survival, including a nationwide health program for CRC treatment access (GES program).

methodsPublicly available data published by the Ministry of Health and National Institute of Statistics were used. Data were obtained from registries of mortality and hospital discharges, making follow-up of the individuals possible. Crude and age-standardized incidence and mortality rates were calculated, and individual survival was studied by constructing Kaplan-Meier curves. Finally, a Cox statistical model was established to estimate the impact of the observable factors.

resultsWe found 37,217 newly identified CRC patients between 2008 and 2019 in Chile, corresponding to 103,239 hospital discharges. In the same period, 24,217 people died of CRC. A nearly linear, steady increase in crude incidence, mortality and prevalence was observed. CRC incidence was the lowest in the North of the country, increasing toward the South and reaching a maximum value of 34.6/100,000 inhabitants/year in terms of crude incidence and 20.7/100,000 inhabitants/year in terms of crude mortality in the XII region in 2018. We found that older patients had lower survival rates, as well as men compared to women. Survival was significantly better for patients with private insurance than those under the public insurance system, and the treating hospital also played a significant role in the survival of patients. Patients in the capital region survived longer than those in almost every other part of the country. We found no significant effect on survival associated with the GES program.

conclusionsWe found important inequalities in the survival probabilities for CRC patients in Chile. Survival depends mainly on the type of insurance, access to more complex hospitals, and geographical location; all three factors correlated with socioeconomic status of the population. Our work emphasized the need to create specific programs addressing primary causes to decrease the differences in CRC survival.

Indexed as

Colorectal NeoplasmsChileFemaleHumansIncidenceMaleRegistriesSocioeconomic FactorsSurvival RateUnited States

Identifiers

PMID36355864
PMCPMC9648833
OpenAlexW4308701412

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.